| |
|
|
AAA (continued)
|
| |
Chairmen |
|
Michel Bartoli, Frédéric Cochennec, Matt Thompson, Hence Verhagen |
| |
14.00 |
|
Short neck aneurysms
|
| |
|
|
Round table. How short neck AAA should be repaired |
| |
14.00 |
|
Open repair remain the best treatment, Michel Makaroun  |
| |
14.08 |
|
Not at all, F EVAR offers excellent immediate and long term results, Eric Verhoeven |
| |
14.16 |
|
Parralel grafts are the best option and can be standardized, Donas Konstantinos |
| |
14.24 |
|
Why EVAS is the best graft for chimneys ? Ian Loftus |
| |
14.32 |
|
Forget the dialectic, choose the technique according to the patient’s anatomy, Eric Ducasse |
| |
14.40 |
|
Discussion |
| |
14.50 |
|
Endoleaks |
| |
|
|
Type II endoleaks |
| |
14.50 |
|
What did I learn from the systematic review on treatment success for type II endoleak,
Hence Verhagen |
| |
|
|
Techniques you must know to deal with type I proximal endoleak |
| |
14.58 |
|
How I do a chimney to treat Type A endoleak, Claude Mialhe |
| |
15.06 |
|
How I do a F and B graft, Tim Resch |
| |
15.14 |
|
How I put a screw to fix the problem, Jean-Paul de Vries |
| |
15.22 |
|
Discussion |
| |
15.30 |
|
Break in the exhibition hall  |
| |
|
|
CAROTID |
| |
Chairmen |
|
Alan Dardik, Michel Ferdani, Ravish Sachar, Peter Schneider, Frank Veith |
| |
16.00 |
|
Risk of stroke and how to make a decision? |
| |
16.00 |
|
The keys to understanding stroke risk in asymptomatic carotid disease - Individual patient data meta-analysis of VA, ACAS and ACST-1 trials, Richard Bulbulia |
| |
16.08 |
|
Progression of asymptomatic carotid stenosis: is it a risk factor of stroke? Stravos Kakkos |
| |
16.16 |
|
Internal carotid artery near-total occlusions is it justified to operate on them ? Christos Liapis |
| |
16.24 |
|
Carotid plaque morphology is only relevante to consider in symptomatic carotic stenosis,
Henrik Sillesen |
| |
16.32 |
|
Discussion |
| |
16.40 |
|
CAS is back: what are the recent improvements which make CAS safer? |
| |
16.40 |
|
Which clinical and procedural variables modify the perioperative risk of CEA in symptomatic patients – data from ICSS, CREST, EVA3-S and SPAC, Hans-Henning Eckstein |
| |
16.48 |
|
Lessons drawn from the extensive review of CPD, Sandrine Egron |
| |
16.56 |
|
Forget filters, cervical access with reverse flow is a game changer, Jordi Maeso Lebrun |
| |
17.04 |
|
CEA results are the best ever why? |
| |
17.04 |
|
Delay between symptoms and interventions matters, Ian Loftus |
| |
17.12 |
|
Quality control by duplex or angio is crucial to reduce P.O. stroke, Hans-Henning Eckstein |
| |
17.20 |
|
Do minimal incisions for CEA reduce peripheral nerves damage and P.O. strokes, Robert Proczka |
| |
17.28 |
|
Discussion |
| |
17.40 |
|
Challenging carotid lesions |
| |
17.40 |
|
Technical keys to approach the carotid at the basis of the skull, Marc Coggia |
| |
17.48 |
|
Carotid stenting in complement of CEA, Yves Alimi |
| |
17.56 |
|
Reintervention following CAS and CEA: when and how? Carlo Setacci |
| |
18.04 |
|
How to prevent surgical complications of carotid body tumor resection? George Geroulakos |
| |
18.12 |
|
Discussion |
| |
|
|
SPECIAL ISSUES: VASCULAR SURGEONS AT WAR |
| |
18.15 |
|
Terrorists attacks in Paris: dealing with multiple vascular traumas, Philippe Tresson |
| |
18.25 |
|
Endovascular management of acute aortic trauma, Sherif Sultan |
| |
18.35 |
|
End of the session |
